APOE genotype, lipids, and coronary heart disease risk: a prospective population study.
paper
Cited
Public
Unavailable
- Authors
- Ward, Heather; Mitrou, Panagiota N; Bowman, Richard; Luben, Robert; Wareham, Nicholas J; Khaw, Kay-Tee; Bingham, Sheila
- Year
- 2009
- Journal
- Archives of internal medicine
- PMID
- 19667307
- DOI
- 10.1001/archinternmed.2009.234
BACKGROUND: The risk of coronary heart disease (CHD) may be related to genetic mutations in the production of apolipoprotein E via alterations to the metabolism of CHD-related blood lipids such as low-density lipoprotein cholesterol and triglycerides. METHODS: The relationship between APOE genotype (*E3/*E3, *E3/*E4, *E2/*E3, *E4/*E4, *E2/*E4, and *E2/*E2) and fatal and nonfatal CHD was examined among 10 035 men and 12 134 women, aged 440 to 79 years, from the Norfolk, England, arm of the European Prospective Into Nutrition and Cancer Study (1993-2007). During an average of 11 years of follow-up, 2712 CHD events were documented. RESULTS: The hazard ratio for CHD was 0.88 (95% confidence interval, 0.77-0.99) for *E2 carriers (*E2/*E2 and *E2/*E3) and 1.09 (1.00-1.19) for *E4 carriers (*E3/*E4 and *E4/*E4) compared with homozygous *E3/*E3 individuals after age and sex adjustment. Similar values were obtained when systolic blood pressure, body mass index, diabetes mellitus, alcohol intake, physical activity, and smoking were added to the model. After additional adjustment for baseline levels of the ratio of low- to high-density lipoprotein cholesterol, the hazard ratios (and 95% confidence intervals) for *E2 and *E4 carriers were 0.97 (0.85-1.10) and 1.06 (0.97-1.15), respectively, when compared with *E3 homozygotes. No interactions by sex, smoking status, or age groups were observed. CONCLUSION: In the largest prospective cohort study to date, CHD risk was not associated with APOE genotype after controlling for a variety of cardiovascular risk factors, particularly the ratio of low- to high-density lipoprotein cholesterol.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Candidate gene-environment interaction research: reflections and recommendations. | 2015 | 25620996 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Relationships Between APOE, Type 2 Diabetes, and Cardiovascular Disease in Postmenopausal Women. | Dunk MM et al. | β | 2025 | β |
| The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence. | Oyovwi MO et al. | β | 2025 | β |
| Apolipoprotein E-Ξ΅2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study. | Toribio-FernΓ‘ndez R et al. | β | 2024 | β |
| Association of epistatic effects of MTHFR, ACE, APOB, and APOE gene polymorphisms with the risk of myocardial infarction and unstable angina in Egyptian patients. | Taha M et al. | β | 2024 | β |
| Genetically Predicted Apolipoprotein E Levels with the Risk of Panvascular Diseases: A Mendelian Randomization Study. | Shi YM et al. | β | 2024 | β |
| Genetic Polymorphisms and Genetic Risk Scores Contribute to the Risk of Coronary Artery Disease (CAD) in a North Indian Population. | Mastana S et al. | β | 2024 | β |
| Effect of ApoE Ξ΅4 gene polymorphism on the correlation between serum uric acid and left ventricular hypertrophy remodeling in patients with coronary heart disease. | Liu J et al. | β | 2022 | β |
| Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus. | Ozuynuk AS et al. | β | 2022 | β |
| Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: Results from a 15Β year follow-up study. | Pitchika A et al. | β | 2022 | β |
| Mediation of the APOE associations with Alzheimer's and coronary heart diseases through body mass index and lipids. | Loika Y et al. | β | 2022 | β |
| The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. | Innes H et al. | β | 2022 | β |
| Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Hakka postmenopausal women in southern China. | Hou J et al. | β | 2020 | β |
| DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular health. | Mur J et al. | β | 2020 | β |
| Genetic polymorphisms in early-onset myocardial infarction in a sample of Iraqi patients: a pilot study. | Mohammad AM et al. | β | 2020 | β |
| Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study. | Santos-Ferreira C et al. | β | 2019 | β |
| A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward. | Belloy ME et al. | β | 2019 | β |
| Association between APOE polymorphisms and lipid profile in Mexican Amerindian population. | MartΓnez-MagaΓ±a JJ et al. | β | 2019 | β |
| Gene Polymorphisms of Methylenetetrahydrofolate Reductase and Apolipoprotein E: Causes or Markers for Coronary Artery Disease? | Chen JY et al. | β | 2019 | β |
| Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China. | Zhong Z et al. | β | 2018 | β |
| APOE Gene polymorphism among Jordanian Alzheimer`s patients with relation to lipid profile. | Shafagoj YA et al. | β | 2018 | β |
| Effects of polymorphisms in APOB, APOE, HSD11Ξ²1, PLIN4, and ADIPOQ genes on lipid profile and anthropometric variables related to obesity in children and adolescents. | Gasparin CC et al. | β | 2018 | β |
| The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases. | Rubattu S et al. | β | 2018 | β |
| Apolipoprotein E: the resilience gene. | James LM et al. | β | 2017 | β |
| Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. | Larifla L et al. | β | 2017 | β |
| Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders. | de Pedro-Cuesta J et al. | β | 2016 | β |
| Genetic Research and Women's Heart Disease: a Primer. | Kavousi M et al. | β | 2016 | β |
| Serum apolipoprotein E concentration and polymorphism influence serum lipid levels in Chinese Shandong Han population. | Han S et al. | β | 2016 | β |
| The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial. | Fallaize R et al. | β | 2016 | β |
| APOE gene polymorphism and risk of coronary stenosis in Pakistani population. | Cheema AN et al. | β | 2015 | β |
| Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels. | Borilova Linhartova P et al. | β | 2015 | β |
| C2238/Ξ±ANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro. | Stanzione R et al. | β | 2015 | β |
| Candidate gene-environment interaction research: reflections and recommendations. | Dick DM et al. | β | 2015 | β |
| Common low-density lipoprotein receptor p.G116S variant has a large effect on plasma low-density lipoprotein cholesterol in circumpolar inuit populations. | DubΓ© JB et al. | β | 2015 | β |
| Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study. | Ma Y et al. | β | 2015 | β |
| Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction. | Karahan Z et al. | β | 2015 | β |
| Selenium Level and Dyslipidemia in Rural Elderly Chinese. | Su L et al. | β | 2015 | β |
| APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms. | Conejero-Goldberg C et al. | β | 2014 | β |
| Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? | Chouinard-Watkins R et al. | β | 2014 | β |
| Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity. | Hinney A et al. | β | 2014 | β |
| Apolipoprotein E gene polymorphism, alcohol use, and their interactions in combat-related posttraumatic stress disorder. | Kim TY et al. | β | 2013 | β |
| Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. | Khan TA et al. | β | 2013 | β |
| Association between APOE, SCARB1, PPARΞ± polymorphisms and serum lipids in a population of Lithuanian adults. | Smalinskiene A et al. | β | 2013 | β |
| KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients. | Sabbagh M et al. | β | 2013 | β |
| Smoking, apolipoprotein E genotypes, and mortality (the Ludwigshafen RIsk and Cardiovascular Health study). | Grammer TB et al. | β | 2013 | β |
| The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains. | Leuthold AC et al. | β | 2013 | β |
| Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. | Wu Y et al. | β | 2013 | β |
| ApoE isoforms, treatment of diabetes and the risk of coronary heart disease. | Ehara H et al. | β | 2012 | β |
| Apolipoprotein E polymorphism is associated with both number of diseased vessels and extent of coronary artery disease in Czech patients with CAD. | Machal J et al. | β | 2012 | β |
| Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population. | Petkeviciene J et al. | β | 2012 | β |
| Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? | Bozok Cetintas V et al. | β | 2012 | β |
| Familial genetic risk factors in premature cardiovascular disease: a family study. | Yucel O et al. | β | 2012 | β |
| Human apolipoprotein E genotypes differentially modify house dust mite-induced airway disease in mice. | Yao X et al. | β | 2012 | β |
| Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. | Gustavsson J et al. | β | 2012 | β |
| The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes). | McIntosh AM et al. | β | 2012 | β |
| The apolipoprotein E polymorphism and cardiovascular diseases--an autopsy study. | Kumar NT et al. | β | 2012 | β |
| A functional mutation at position -155 in porcine APOE promoter affects gene expression. | Li S et al. | β | 2011 | β |
| Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy. | Baptista R et al. | β | 2011 | β |
| Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients. | Addante F et al. | β | 2011 | β |
| Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk. | Nordestgaard BG et al. | β | 2011 | β |
| Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. | Calandra S et al. | β | 2011 | β |
| Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. | McKay GJ et al. | β | 2011 | β |
| APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. | Alvim RO et al. | β | 2010 | β |
| Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly. | Haan MN et al. | β | 2010 | β |
| Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study. | Davis WA et al. | β | 2010 | β |
| Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study. | Irvin MR et al. | β | 2010 | β |